BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26003547)

  • 1. Encapsulated Thyroid Carcinoma of Follicular Cell Origin.
    Xu B; Ghossein R
    Endocr Pathol; 2015 Sep; 26(3):191-9. PubMed ID: 26003547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulated malignant follicular cell-derived thyroid tumors.
    Ghossein R
    Endocr Pathol; 2010 Dec; 21(4):212-8. PubMed ID: 21088998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).
    Rivera M; Tuttle RM; Patel S; Shaha A; Shah JP; Ghossein RA
    Thyroid; 2009 Feb; 19(2):119-27. PubMed ID: 19191744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.
    Liu J; Singh B; Tallini G; Carlson DL; Katabi N; Shaha A; Tuttle RM; Ghossein RA
    Cancer; 2006 Sep; 107(6):1255-64. PubMed ID: 16900519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma.
    Kim TH; Lee M; Kwon AY; Choe JH; Kim JH; Kim JS; Hahn SY; Shin JH; Chung MK; Son YI; Ki CS; Yim HS; Kim YL; Chung JH; Kim SW; Oh YL
    Histopathology; 2018 Mar; 72(4):648-661. PubMed ID: 28940583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma.
    Howitt BE; Jia Y; Sholl LM; Barletta JA
    Thyroid; 2013 Oct; 23(10):1256-62. PubMed ID: 23477374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification of follicular variant of papillary thyroid carcinoma.
    Vivero M; Kraft S; Barletta JA
    Thyroid; 2013 Mar; 23(3):273-9. PubMed ID: 23025507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort.
    Chung R; Guan H; Ponchiardi C; Cerda S; Marwaha N; Yilmaz OH; Pinjic E; McAneny D; Lee SL; Drake FT
    Thyroid; 2021 Jan; 31(1):68-75. PubMed ID: 32539676
    [No Abstract]   [Full Text] [Related]  

  • 9. Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison.
    Finnerty BM; Kleiman DA; Scognamiglio T; Aronova A; Beninato T; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2015 Apr; 22(4):1200-6. PubMed ID: 25297901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases.
    Xu B; Wang L; Tuttle RM; Ganly I; Ghossein R
    Hum Pathol; 2015 Dec; 46(12):1789-98. PubMed ID: 26482605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
    Xu B; Tallini G; Scognamiglio T; Roman BR; Tuttle RM; Ghossein RA
    Thyroid; 2017 Apr; 27(4):512-517. PubMed ID: 28136139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study.
    Evans HL; Vassilopoulou-Sellin R
    Am J Surg Pathol; 1998 Dec; 22(12):1512-20. PubMed ID: 9850177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
    Eloy C; Santos J; Soares P; Sobrinho-Simões M
    Virchows Arch; 2011 Dec; 459(6):595-605. PubMed ID: 22081104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.
    Xu B; Reznik E; Tuttle RM; Knauf J; Fagin JA; Katabi N; Dogan S; Aleynick N; Seshan V; Middha S; Enepekides D; Casadei GP; Solaroli E; Tallini G; Ghossein R; Ganly I
    Endocrine; 2019 Apr; 64(1):97-108. PubMed ID: 30689169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?
    Xu B; Farhat N; Barletta JA; Hung YP; Biase D; Casadei GP; Onenerk AM; Tuttle RM; Roman BR; Katabi N; Nosé V; Sadow P; Tallini G; Faquin WC; Ghossein R
    Endocrine; 2018 Jan; 59(1):143-150. PubMed ID: 29204912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant.
    Ganly I; Wang L; Tuttle RM; Katabi N; Ceballos GA; Harach HR; Ghossein R
    Hum Pathol; 2015 May; 46(5):657-64. PubMed ID: 25721865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Profile and Clinicopathologic Features of Follicular Variant Papillary Thyroid Carcinoma.
    Sohn SY; Lee JJ; Lee JH
    Pathol Oncol Res; 2020 Apr; 26(2):927-936. PubMed ID: 30900082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Two Distinct Molecular Subtypes of Non-Invasive Follicular Neoplasm with Papillary-Like Nuclear Features by Digital RNA Counting.
    Giannini R; Ugolini C; Poma AM; Urpì M; Niccoli C; Elisei R; Chiarugi M; Vitti P; Miccoli P; Basolo F
    Thyroid; 2017 Oct; 27(10):1267-1276. PubMed ID: 28679352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
    Giani C; Torregrossa L; Ramone T; Romei C; Matrone A; Molinaro E; Agate L; Materazzi G; Piaggi P; Ugolini C; Basolo F; Ciampi R; Elisei R
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4072-e4083. PubMed ID: 34231847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts.
    Wallander M; Layfield LJ; Jarboe E; Emerson L; Liu T; Thaker H; Holden J; Tripp S
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):231-5. PubMed ID: 20042852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.